Hosted on MSN2h
Researchers expect FDA to approve a twice-yearly shot that reduces risk of HIV infection by 96%Roughly 61,000 Georgians live with HIV, the sexually transmitted virus (STI) that can lead to AIDS, and Atlanta ranks in the ...
WHO is convening a Guideline Development Group (GDG) for the development of new guidelines on the use of injectable ...
A milestone was reached in the fight against HIV/AIDS with the development of Lenacapavir, a new injectable drug that ...
A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.
The US drug administration has approved the use of the medication as an injection for use against the multidrug resistant ...
In Donald Trump’s 2019 State of the Union Address, he made “a commitment to eliminate the HIV epidemic in the United States ...
The trial was a tremendous success and showed dramatically lower HIV transmission than with the oral drug." Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug ...
Wesley Sundquist’s lab laid foundation for development of a highly effective, long-lasting preventive measure against HIV.
Lenacapavir, approved by the US FDA, presents a groundbreaking advancement in the battle against HIV. Developed by Gilead ...
7don MSNOpinion
This year saw several advancements across medicine, space technology, and AI that extend our knowledge in consequential ways.
NEW DELHI: In a major step forward in the fight against HIV/AIDS, the US Food and Drug Administration (FDA) has approved Lenacapavir, an injectable HIV drug. This drug protects people for six ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback